Rare diseases
Investigational molecules
Locations
301 Carlson Parkway Suite 210, 55305-5357, United States
Diamedica Therapeutics Inc. focuses on clinical research in acute ischemic stroke, with attention to patients presenting after the onset of neurological injury and those with moderate stroke severity.
The sponsor’s research interest is centered on stroke populations with limited treatment options, particularly cases involving small vessel and medium vessel occlusions.
Diamedica Therapeutics Inc. runs clinical trials in conditions such as Ischaemic stroke, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
